You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Venugopal I, DeLong MN, Powell AG, et al
839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0839